How To Select The Right Bioanalysis CRO For Your Program

For biotech companies, choosing the right bioanalysis CRO partner can be the difference between accelerating a program and watching it stall. No organization wants to become another cautionary tale of delays, miscommunication, and hidden fees. The truth is simple: the right bioanalysis CRO acts as a strategic accelerator, while the wrong one can slow progress and jeopardize outcomes. But when every provider promises speed and credibility, how can you confidently identify the right partner?

Join Ander Tallett, Co-Founder and Chief Operating Officer of Dash Bio and former Head of Procurement at Moderna, for an unfiltered exploration of the realities behind bioanalysis CRO selection. Drawing from deep experience in building technology-driven R&D platforms, Ander will share practical insights into navigating common challenges, recognizing red flags, and finding solutions that align with your program’s pace and goals.

Key learning objectives:

• Challenge industry norms: Discover how technology can truly accelerate bioanalysis and how to set realistic expectations for faster, more reliable timelines.
• Cut through opacity: Learn to assess CRO pricing models, uncover hidden costs, and secure transparent, predictable budgets.
• Reclaim control: Gain strategies for managing CRO relationships effectively to foster partnerships that drive progress rather than hinder it.